INFLUENCE OF FOOD ON THE ABSORPTION OF PHENYTOIN IN MAN

被引:52
作者
MELANDER, A
BRANTE, G
JOHANSSON, O
LINDBERG, T
WAHLINBOLL, E
机构
[1] MALMO GEN HOSP,DEPT PEDIAT,S-21401 MALMO,SWEDEN
[2] UNIV LUND,ST LARS HOSP,S-22101 LUND,SWEDEN
关键词
bioavailability; food-intake; pharmacokinetics; phenytoin;
D O I
10.1007/BF00618516
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influence of food intake on the absorption of phenytoin was examined in eight healthy volunteers, by study of single-dose kinetics following ingestion of phenytoin 300 mg either with a standardized breakfast or on an empty stomach. Blood samples were collected at regular intervals from 0 to 48 h, and serum concentrations of unmetabolized phenytoin were determined by gas chromatography. Serum concentrations of the major metabolite of phenytoin, 4-hydroxyphenytoin, were measured by mass fragmentography. Concurrent intake of food and phenytoin appeared to accelerate absorption of the drug from the formulation used, and the peak concentrations were significantly higher (mean increase 40%) in the postprandial than in the preprandial state. As reflected by the AUC (area under the curve), the amount of drug absorbed was increased during postprandial conditions, although the difference only reached borderline significance. It is suggested that phenytoin should always be taken in a defined relation to meals. © 1979 Springer-Verlag.
引用
收藏
页码:269 / 274
页数:6
相关论文
共 26 条
[1]  
Alvan G, 1975, Lakartidningen, V72, P2621
[2]   MICROMETHOD FOR DETERMINATION OF DIPHENYLHYDANTOIN IN PLASMA AND CEREBROSPINAL-FLUID - COMPARISON BETWEEN A GAS-CHROMATOGRAPHIC AND A SPECTROPHOTOMETRIC METHOD [J].
BERLIN, A ;
BORGA, O ;
AGURELL, S ;
SJOQVIST, F ;
LUND, L .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1972, 29 (03) :281-&
[3]  
CONNEY AH, 1976, CLIN PHARMACOL THER, V20, P633
[4]  
FREDHOLM B, 1974, PHARMACEUTIC ANNUAL
[5]  
GLAZKO AJ, 1972, PHARMACOLOGY, V8, P163
[6]   MASS FRAGMENTOGRAPHIC DETERMINATION OF DIPHENYLHYDANTOIN AND ITS MAIN METABOLITE, 5-(4-HYDROXYPHENYL)-5-PHENYLHYDANTOIN, IN HUMAN PLASMA [J].
HOPPEL, C ;
GARLE, M ;
ELANDER, M .
JOURNAL OF CHROMATOGRAPHY, 1976, 116 (01) :53-61
[7]  
JOHANNESSEN SI, 1975, CLIN PHARM ANTIEPILE, P262
[8]   EVALUATION OF SPIRAMYCIN AS A THERAPEUTIC AGENT FOR ELIMINATION OF NASOPHARYNGEAL PATHOGENS - POSSIBLE USE OF SPIRAMYCIN FOR MIDDLE-EAR INFECTIONS AND FOR GONOCOCCAL AND MENINGOCOCCAL NASOPHARYNGEAL CARRIAGE [J].
KAMME, C ;
KAHLMETER, G ;
MELANDER, A .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1978, 10 (02) :135-142
[9]  
KAPPAS A, 1976, CLIN PHARMACOL THER, V20, P643
[10]  
LaDu B. N., 1971, FUNDAMENTALS DRUG ME, P36